Company / Gross Profit
Veracyte, Inc. Gross Profit History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$362.5M
FY2025
5-year range
$175.7M / $362.5M
FY2022-FY2025
Trend
+21.6%
vs FY2024
Sector context
#63 of 95
Health Care
What the data says
At $363M, Veracyte, Inc.'s gross profit ranks #63 of 95 in the Health Care sector. Gross Profit has increased for 3 consecutive years, from $176M in FY2022 to $363M in FY2025.
Based on SEC 10-K filings.
$363M in FY2025 with a 3-year CAGR of +27.3%.
Improved from $230M to $363M over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +27.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#63 of 95 in Health CareTop 66% of 95This company $362.5M Sector average $1.9B
▼
-80.7% below sector average
Key checks
Key Insights
- Veracyte, Inc.'s gross profit has grown for 3 consecutive years.
- 3-year CAGR of +27.3%, indicating consistent growth.
- In FY2025, gross profit increased 21.6% year-over-year.
- Ranks #63 out of 95 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 6.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $362.5M | +21.6% |
| FY2024 | $298.1M | +29.8% |
| FY2023 | $229.7M | +30.7% |
| FY2022 | $175.7M | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026